Hosted on MSN2m
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause Nausea
"While GLP-1-based therapies have revolutionized patient ... and diabetes who are unable to tolerate existing treatments. The ...
Hosted on MSN47m
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation
Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream. The ...